HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Personal Care Products In Court: Clinique May Settle Probiotic Suit; ‘99.99% Of Germs’ Sanitizer Update

Executive Summary

The latest on proposed false-advertising class actions targeting Clinique Laboratories for probiotic representations and leading hand sanitizer manufacturers for “kills 99.99% of germs” claims.

You may also be interested in...



Hard To Kill: Class Actions Drag On Against Sanitizer Lethality Claims

Plaintiffs are down, but not out, with allegations of false advertising against hand sanitizer manufacturers using 99.99% germ-killing claims.

ACI’s Antiseptic Testing Continues Under Specter Of FDA Administrative Order

The American Cleaning Institute is preparing to submit a healthcare personnel hand wash study to the US FDA pending confidentiality discussions, along with results from a literature review on the topic of antimicrobial resistance. A progress report is due to the agency in October, which could stave off an administrative order under the reformed OTC drug review system.

Clinique Probiotic Claims Challenged In Proposed US Class Action

The false advertising case in New York federal court is one to watch for any cosmetics company using probiotic claims. Are consumers of “probiotic”-containing cosmetics getting what they reasonably expect?

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS151369

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel